1. What is the Chemxpert database?

Chemxpert database is a techno-commercial information platform developed and operated by Lifescience Intellipedia Pvt. Ltd. Our data provides valuable insights regarding sourcing, marketing, development, and regulatory functions for the entire Lifescience industry. The different industries covered by our data encompass APIs, FDFs, pharma intermediates, paints, dyes, polymers, biotechnology, biochemical, food additives, nutraceuticals, etc.

2. How can I subscribe to the Chemxpert database?

You can gain access to the Chemxpert database after subscribing to it by visiting this link: - https://chemxpert.com/pricing

3. How many countries' data is available on your portal?

The Chemxpert database covers more than 200 countries. We are working in the direction of expanding our data coverage in more countries.

4. What are the different sources you use for obtaining information?

The different sources we use for data collection are as follows: - • Primary researc • DMF, ANDA, & CEP list • Conferences, Exhibitions, & Tradeshow • Company annual reports • DMF, ANDA, & CEP list • Subject matter experts & KOL survey. Apart from these, our other valuable sources include application-wise manufacturers list, subscribed and non-subscribed databases, corporate partners, US FDA Orange book, publicly available sources, industry associates, national statistics, regulatory websites, etc. You can gain access to the Chemxpert database after subscribing to it by visiting this link: -https://chemxpert.com/sources

5. What is the expected time for account activation?

Your Chemxpert account will be activated instantly if the payment is made through our website. If you choose to use RTGS, NEFT, or IMPS systems for payment, your account will be activated within 24 hours.

09 Feb 2024
Admin
News Article

Pacira Biosciences Agreement with Premier Inc

Pacira Biosciences Secures Agreement for Brand Pharmaceuticals with Premier, Inc

Pacira BioSciences, Inc.

known for its focus on non-opioid pain management and regenerative health solutions, has secured a national group purchasing agreement for Brand Pharmaceuticals with Premier, Inc. This agreement, effective from January 1, 2024, enables Premier members to access special pricing and terms for EXPAREL® (bupivacaine liposome injectable suspension).

The partnership aims to enhance patient care and drive cost efficiencies for healthcare organizations, allowing Premier members to utilize EXPAREL. This innovative single-dose local and regional analgesic offers extended postsurgical pain relief while reducing reliance on opioids.

Pacira BioSciences, expressed enthusiasm about the collaboration, stating, “Premier boasts an extensive network of U.S. hospitals and health systems, presenting Pacira with an exceptional avenue to broaden its reach while elevating patient safety and care. We take pride in partnering with organizations like Premier as we strive to expand access to non-opioid pain management solutions for patients nationwide.”

Aligned in their mission to drive innovation, enhance patient outcomes, and deliver value in healthcare, Pacira and Premier anticipate significant contributions through this collaboration. By uniting approximately 4,350 U.S. hospitals and 300,000 providers, Premier, a leading healthcare improvement company, leverages integrated data, analytics, and various services to facilitate better care and outcomes at reduced costs.

Let’s apply Data-Driven Pricing to Your APIs

Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.

Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.

Start using market intelligence today and allow yourself to be in control in the API market.

Check it out today and make more informed sourcing decisions! Learn More!